From: Becker's Supply Chain Report <>
Subject: Drug shortages expected as Hospira's manufacturing issues linger | 4 PBMs must face lawsuit over EpiPen prices, judge rules | CHS' net loss swells to $325M in Q3 | Deficient pharmacy practices jeopardize Alaska hospital's Medicare contract
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube

October 31, 2018
1. Drug shortages expected as Pfizer's manufacturing issues linger 
2. UnitedHealth, CVS, Express Scripts, Prime must face lawsuit over EpiPen prices  Full story

3. Utah insurer will pay for members' travel to Mexico to fill pricey prescriptions  Full story

4. Join Becker's for a 3-day Virtual Health IT Summit to hear from industry leaders about the future of care delivery.
Click here to register.

5. CHS sees net loss swell to $325M in Q3 

6. Alaska hospital may lose its Medicare funding over deficient pharmacy practices  Full story
7. Learn all you need to know about keeping critical systems operational and sensitive data secure.

8. J&J loses patent fight over prostate cancer blockbuster
9. Ochsner Health, Walmart to launch accountable care plan in Louisiana  Full story
10. UPMC physician among 11 killed in Pittsburgh synagogue shooting  Full story
11. Learn how 2 hospitals elevated patient care with remote pharmacy services during this upcoming webinar.

12. Pfizer will likely hike drug prices come January 

Contact Us

Editorial Contact: 
Molly Gamble 
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO
Becker's Hospital Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by in collaboration with
Constant Contact